Log in

ASX:UCMUscom Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 9247 4144

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.12 million
Book ValueA$0.02 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive UCM News and Ratings via Email

Sign-up to receive the latest news and ratings for UCM and its competitors with MarketBeat's FREE daily newsletter.

Uscom (ASX:UCM) Frequently Asked Questions

Has Uscom been receiving favorable news coverage?

Headlines about UCM stock have trended somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Uscom earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutUscom.

Who are some of Uscom's key competitors?

Who are Uscom's key executives?

Uscom's management team includes the following people:
  • Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR, Founder, Exec. Chairman, CEO & Chief Scientist (Age 67)
  • Mr. Brett Crowley, Company Sec. & Non-Exec. Director (Age 63)
  • Mr. Nicholas Schicht, Gen. Mang. (Age 54)

What is Uscom's stock symbol?

Uscom trades on the ASX under the ticker symbol "UCM."

How big of a company is Uscom?

Uscom has a market capitalization of $0.00 and generates $3.12 million in revenue each year.

What is Uscom's official website?

The official website for Uscom is www.uscom.com.au.

How can I contact Uscom?

The company can be reached via phone at 61 2 9247 4144.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.